LOADING
Comparing Merck & Company (MRK) and Snap Inc (SNAP) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | SNAP |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $294.4B | $10.2B |
| P/E Ratio | 16.4 | -- |
| Forward P/E | 23.3 | 13.1 |
| PEG Ratio | 3.64 | 496.06 |
| EPS | $7.28 | $-0.27 |
| Revenue Growth (YoY) | 5.0% | 10.2% |
| Profit Margin | 28.1% | -7.8% |
| Return on Equity | 36.9% | -19.5% |
| Dividend Yield | 2.81% | -- |
| Beta | 0.28 | 0.91 |
| 52-Week High | $124.22 | $10.41 |
| 52-Week Low | $70.74 | $3.81 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.